Corient Private Wealth’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $428K | Sell |
8,144
-1,655
| -17% | -$87K | ﹤0.01% | 1872 |
|
2025
Q1 | $625K | Buy |
9,799
+4,020
| +70% | +$257K | ﹤0.01% | 1490 |
|
2024
Q4 | $276K | Sell |
5,779
-14,464
| -71% | -$692K | ﹤0.01% | 1940 |
|
2024
Q3 | $1.16M | Sell |
20,243
-7,410
| -27% | -$424K | ﹤0.01% | 1312 |
|
2024
Q2 | $1.45M | Buy |
27,653
+5,636
| +26% | +$295K | ﹤0.01% | 1174 |
|
2024
Q1 | $896K | Buy |
22,017
+136
| +0.6% | +$5.53K | ﹤0.01% | 1343 |
|
2023
Q4 | $809K | Buy |
21,881
+3,206
| +17% | +$118K | ﹤0.01% | 1374 |
|
2023
Q3 | $713K | Buy |
18,675
+2,075
| +13% | +$79.3K | ﹤0.01% | 1305 |
|
2023
Q2 | $599K | Buy |
+16,600
| New | +$599K | ﹤0.01% | 1364 |
|
2023
Q1 | – | Sell |
-4,976
| Closed | -$283K | – | 2010 |
|
2022
Q4 | $283K | Buy |
+4,976
| New | +$283K | ﹤0.01% | 1357 |
|